Robert J. “Bob” Appel ’53, a vice chair of Weill Cornell Medication’s Board of Fellows, Cornell trustee emeritus and presidential councillor, died Nov. 19 in New York, at age 91.
An energetic and enthusiastic Cornell alumnus, Appel was a loyal champion, distinguished chief and esteemed benefactor of the Ithaca and Weill Cornell Medication campuses. He was a prodigious advocate of dwelling by instance and, alongside his beloved spouse Helen ’55, took immense delight in advancing Cornell’s mission.
“Bob’s legacy – as a devoted alumnus, volunteer, board member and philanthropist – is enormously far-reaching,” President Martha E. Pollack stated. “He’ll at all times be one of many really nice Cornellians: compassionate, visionary and with a boundless love for Cornell, its individuals and its mission.”
Appel joined the Cornell Board of Trustees in 1996. Throughout his eight-year time period, he served as chair of its Funding Committee and as a member of the Government Committee. Since 2004, Appel has been an emeritus trustee and presidential councillor to 6 presidents.
Bob and Helen’s philanthropy has strengthened the college throughout its campuses. On the Ithaca campus, they supplied assist for quite a few tasks, together with the Appel Commons on North Campus, Lincoln Corridor and the Herbert F. Johnson Museum of Artwork. Throughout the Faculty of Arts and Sciences, they funded presidential analysis scholarships, fellowships for humanists and social scientists, and a professorship in molecular and cell biology. The Appels additionally often volunteered their management, chairing a number of class Reunion marketing campaign committees and co-chairing the Tower Membership.
For these and different achievements, the Appels have been awarded the Frank H.T. Rhodes Exemplary Alumni Service Award this September.
“Bob’s dedication to Cornell and to analysis, discovery and the humanities has and can proceed to learn generations of Cornellians, and for this we’re really grateful,” stated Kraig H. Kayser MBA ’84, chairman of the Cornell Board of Trustees. “By his management, generosity and heat spirit, Bob embodied what it means to be a Cornellian, and he will likely be deeply missed.”
After finishing his time period as trustee in 2004, Appel was elected to Weill Cornell Medication’s Board of Fellows, serving as a vice chair since 2009, in addition to a member of the Government, Membership & Governance, and Growth committees.
For practically twenty years, Appel indefatigably advocated for Weill Cornell Medication’s imaginative and prescient of excellence in medication and science. He cared profoundly about impactful philanthropy – how giving may be transformative in extraordinary methods – and impressed Weill Cornell Medication’s numerous donors to advance the establishment’s mission.
His achievements are embodied within the Discoveries that Make a Distinction marketing campaign that he chaired, which surpassed all targets with greater than $1.6 billion raised for Weill Cornell Medication. They’re additionally mirrored within the Helen and Robert Appel Alzheimer’s Illness Analysis Institute, which he and Helen generously established to root out the scourge of neurodegenerative illnesses. Appel’s legacy can even endure within the Belfer Analysis Constructing, which he helped fund, and within the invaluable assist he supplied to Weill Cornell Medication’s school.
“Bob was an enormous within the Weill Cornell Medication group who put his coronary heart into every part he did,” stated Jessica M. Bibliowicz ’81, chairman of the Weill Cornell Medication Board of Fellows. “A tireless champion of our establishment, he’ll lengthy be remembered for his ardour for well being care, his dedication to curing Alzheimer’s illness and his dedication to bettering the lives of others. He strongly believed within the energy of philanthropy to make the world a greater place – a sentiment that epitomized his and Helen’s beneficiant giving, and galvanized others to do the identical. He will likely be vastly missed by all who have been fortunate sufficient to know him.”
Appel was honorary chair for the present We’re Altering Medication marketing campaign, for which neuroscience is a central pillar.
“Bob’s unwavering dedication to Weill Cornell Medication and the sphere of neuroscience was really visionary,” stated Dr. Augustine M.Ok. Choi, the Stephen and Suzanne Weiss Dean of Weill Cornell Medication. “His steadfast assist has left an indelible mark on our establishment. We’re eternally grateful for his and Helen’s management, which has eternally modified Weill Cornell Medication.”
Appel earned his bachelor’s diploma in economics in 1953 from the Cornell Faculty of Arts and Sciences, and an MBA in 1955 from The Wharton Faculty of the College of Pennsylvania. He devoted his profession to funding administration, serving most lately as president of Appel Associates, an funding agency he based in 2003. For practically three many years prior, Appel was a accomplice at Neuberger Berman, an funding and securities brokerage agency, the place he was additionally a member of its govt committee.
Charismatic with boundless humor, optimism and candor, Appel was additionally a member of NewYork-Presbyterian’s Board of Trustees and chairman emeritus of Jazz at Lincoln Middle.
He’s survived by his spouse, daughters Susan Appel Slavin and Debra Appel Weinreich, and three grandchildren.
A model of this story first appeared on the Cornell Chronicle.